Purpose: This concise review aims to explore the potential for the clinical implementation of artificial intelligence (AI) strategies for detecting glaucoma and monitoring glaucoma progression. / Methods: Nonsystematic literature review using the search combinations "Artificial Intelligence," "Deep Learning," "Machine Learning," "Neural Networks," "Bayesian Networks," "Glaucoma Diagnosis," and "Glaucoma Progression." Information on sensitivity and specificity regarding glaucoma diagnosis and progression analysis as well as methodological details were extracted. / Results: Numerous AI strategies provide promising levels of specificity and sensitivity for structural (e.g. optical coherence tomography [OCT] imaging, fundus photography) and fun...
Glaucomatous optic neuropathy is the leading cause of irreversible blindness worldwide. Diagnosis an...
Artificial intelligence has rapidly evolved from the experimental phase to the implementation phase ...
On September 3, 2020, the Collaborative Community on Ophthalmic Imaging conducted its first 2-day vi...
Purpose: This concise review aims to explore the potential for the clinical implementation of artifi...
Ophthalmology is one of the major imaging-intensive fields of medicine and thus has potential for ex...
Background: Having several applications in medicine, and in ophthalmology in particular, artificial ...
Glaucoma is a leading cause of irreversible vision impairment globally, and cases are continuously r...
Glaucoma is the leading cause of irreversible blindness globally which significantly affects the qua...
Glaucoma is a result of irreversible damage to the retinal ganglion cells. While an early interventi...
Currently, the early diagnosis of glaucoma and monitoring of disease progression is difficult and re...
PURPOSE OF REVIEW: Current recommendations for glaucoma screening are decidedly neutral. No studies ...
: In recent years, the role of artificial intelligence (AI) and deep learning (DL) models is attract...
Artificial Intelligence is a rapidly expanding field within computer science that encompasses the em...
Glaucoma is one of the primary causes of vision loss around the world, necessitating accurate and ef...
GAMMA Challenge is organized to encourage the AI models to screen the glaucoma from a combination of...
Glaucomatous optic neuropathy is the leading cause of irreversible blindness worldwide. Diagnosis an...
Artificial intelligence has rapidly evolved from the experimental phase to the implementation phase ...
On September 3, 2020, the Collaborative Community on Ophthalmic Imaging conducted its first 2-day vi...
Purpose: This concise review aims to explore the potential for the clinical implementation of artifi...
Ophthalmology is one of the major imaging-intensive fields of medicine and thus has potential for ex...
Background: Having several applications in medicine, and in ophthalmology in particular, artificial ...
Glaucoma is a leading cause of irreversible vision impairment globally, and cases are continuously r...
Glaucoma is the leading cause of irreversible blindness globally which significantly affects the qua...
Glaucoma is a result of irreversible damage to the retinal ganglion cells. While an early interventi...
Currently, the early diagnosis of glaucoma and monitoring of disease progression is difficult and re...
PURPOSE OF REVIEW: Current recommendations for glaucoma screening are decidedly neutral. No studies ...
: In recent years, the role of artificial intelligence (AI) and deep learning (DL) models is attract...
Artificial Intelligence is a rapidly expanding field within computer science that encompasses the em...
Glaucoma is one of the primary causes of vision loss around the world, necessitating accurate and ef...
GAMMA Challenge is organized to encourage the AI models to screen the glaucoma from a combination of...
Glaucomatous optic neuropathy is the leading cause of irreversible blindness worldwide. Diagnosis an...
Artificial intelligence has rapidly evolved from the experimental phase to the implementation phase ...
On September 3, 2020, the Collaborative Community on Ophthalmic Imaging conducted its first 2-day vi...